Clinical trial Recruiting at 2 sites Interventional Ages 18 to 100

Adapting the FOCUS Program for LGBTQ+ Cancer Patients and Caregivers

Official title: FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

Run by University of Rochester · NCT06800053 · Data updated 2026-11-12

This trial tests a tailored version of the FOCUS program to see if it helps LGBTQ+ cancer patients and their informal caregivers, compared with a waitlist control.

More Caregivers trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment160 (estimated)
SponsorUniversity of Rochester
Academic / other
Locations2 sites (Detroit, Michigan and 1 other locations)
StatusRecruiting
StartedSeptember 4, 2025
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedAugust 17, 2026
Trial IDNCT06800053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults in the US with a recent invasive cancer diagnosis or progression who identify as LGBTQ+ and have an unpaid caregiver willing to join the program.

Probably not a fit

Patients without an identifiable LGBTQ+ caregiver or those unable to participate in English may not benefit from this adaptation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This two-arm pilot study will enroll 80 SGM cancer patients and at least 80 informal caregivers (total N ≥ 160) across two sites. Participants will be randomized to receive the adapted FOCUS On Us program or a waitlist control. The study aims to assess feasibility and acceptability while exploring potential health and well‑being outcomes for both patients and caregivers. Eligibility includes adults with invasive cancer within the past 24 months, SGM identification (patient or caregiver), English proficiency, and willingness to participate with an unpaid caregiver, with US residency. The investigation is led by Charles Kamen, with Wayne State University and the NCI as collaborators, at Wayne State University and University of Rochester.

Why it matters

Potential benefit: If successful, the program could improve quality of life and support for LGBTQ+ cancer patients and their caregivers.

How similar studies have gone: Prior versions of the FOCUS program have shown benefits in cancer care; this study tests a tailored adaptation for SGM individuals, which is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients must:

1. have been diagnosed or had a biochemical recurrence or progression of any invasive (e.g., Stage ≥1) cancer within the past 24 months;
2. have at least one informal (unpaid) caregiver willing to participate in the program;
3. identify as a sexual and/or gender minority (SGM) OR have a caregiver who identifies as SGM (e.g., either the patient or caregiver(s) must be SGM);
4. be age 18 or older;
5. be able to complete all written and oral components of the study in English;
6. provide informed consent;
7. live in the United States.

Caregivers must:

1. self-report having provided support for a cancer patient as an informal (unpaid) caregiver;
2. have a cancer patient for whom they provided support willing to participate in the program;
3. identify as a sexual and/or gender minority (SGM) OR have provided support to a patient who identifies as SGM (e.g., either the patient or caregiver(s) must be SGM);
4. be age 18 or older;
5. be able to complete all written and oral components of the study in English;
6. provide informed consent;
7. live in the United States

Where it's running

  • Wayne State University
    Detroit, Michigan, United States
    Recruiting
  • University Of Rochester
    Rochester, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.